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Although a premenstrual increase in symptoms can occur Furthermore, the acute rise in NO levels observed during in up to 40% of women with asthma, the mechanisms the late asthmatic response following allergen challenge underlying this phenomenon are poorly understood and correlates with the severity of bronchoconstriction. 11 A have not been frequently evaluated. 1 2 This deterioration recent study in normal women which clearly showed higher may represent an exaggeration of the normal cyclical varilevels of exhaled NO during the luteal phase of the menation in airway function in patients with asthma since a strual cycle may provide a clue to possible airway infall in peak respiratory flow rates occurs even in those flammatory changes in premenstrual asthma. 12 This study patients without significant change in premenstrual sympneeds to be repeated in women with asthma, ideally in toms. 3 Premenstrual worsening of lung function begins those with objective evidence of premenstrual worsening 7-10 days before the onset of menses and peaks 2-3 days of asthma control. The techniques used to process and before their onset. This change in asthma in the latter half analyse sputum samples obtained by induction with hyperof the luteal phase of the menstrual cycle would appear, tonic saline have been refined to show changes in airway on the face of it, to be related to changes in female hormone inflammation clearly, particularly eosinophil function activity. In particular, the observed improvement in severe measured by absolute counts and sputum levels of ECP. 13 premenstrual asthma seen with intramuscular progesterone In combination with measurement of exhaled NO, aswould imply an abnormal level of this hormone during the sessment of sputum eosinophil activity could be readily and late luteal phase of menstruation in this group of patients. 4 safely performed throughout both phases of the menstrual Although the underlying mechanisms are unclear, it cycle of asthmatic patients. seems logical to expect that patients with premenstrual
Tan et al also reported a loss of normal cyclical changes in exacerbations of asthma would exhibit increased airway 2 adrenoceptor regulation previously described in normal responsiveness and evidence of airway inflammation. Surwomen by the same group. 14 This occurred despite an prisingly, the study by Tan et al reported in this issue of appropriate rise in luteal phase sex hormones in the asthThorax is the first to establish clearly an increase in airway matic patients studied. In a previous study from the same responsiveness during the luteal phase of the menstrual group exogenous progesterone upregulated follicular phase cycle. 5 In a group of 15 stable asthmatic women without 2 adrenoceptor function in normal women. 15 Thus, as the premenstrual symptoms, 10 of whom were taking inhaled authors suggest, the present findings may indicate a poor corticosteroids, a 2.5 fold increase in airway responsiveness 2 adrenoceptor response to increased luteal phase endoto adenosine 5′-monophosphate (AMP), an indirect genous progesterone in asthmatic patients. Since female bronchoconstrictor acting predominantly through mast sex steroid hormones potentiate the bronchorelaxant effects cells, 6 was seen. These data contrast with two other studies of catecholamines, 16 this blunted 2 adrenoceptor response in similar groups of mild asthmatic patients, neither of may contribute to the mechanisms underlying prewhich demonstrated changes in airway responsiveness to menstrual asthma. It is not possible to draw any firm methacholine or histamine, direct smooth muscle stimuli. 7 8 conclusions from this study as the patients assessed did This new finding using the indirect stimulus AMP renot have overt premenstrual asthma. The lack of data on quires explanation. The authors postulate that the inpatients with objective premenstrual loss of asthma control creased response to AMP may be due to regulation of hampers the development of insights into this problem. adenosine receptors on airway mast cells under the inAlthough as many as 40% of patients have premenstrual fluence of circulating sex hormones. However, they failed asthma, 1 most are likely to be controlled with standard to find a correlation between circulating hormone levels treatment guidelines including increasing inhaled corticoand changes in PC 20 AMP which makes this unlikely. On steroids and possibly adding long acting 2 adrenoceptor a simple level it seems plausible to believe that, during the agonists during the second half of the menstrual cycle. menstrual cycle, there are changes in asthmatic inStudies are needed to establish clear treatment protocols. flammation within female airways. AMP challenge may be As Tan et al suggest, these studies should include evaluation a more discriminatory tool than the smooth muscle stimuli of theophylline, an adenosine antagonist, 17 and the cromethacholine or histamine as adenosine acts indirectly on mones which effectively attenuate adenosine-induced both airway mast cells and airway sensory nerves. 6 The bronchoconstriction 18 in view of the significant increase in observations of Tan and colleagues may therefore reflect AMP responsiveness during the luteal phase. Of particular upregulation of either or both processes as a measure note, the patients most prone to premenstrual exof increased inflammation. Against this, serum levels of acerbations are those with severe asthma. 4 In many cases eosinophil cationic protein (ECP), a surrogate marker of even high dose oral steroids are of little benefit. In these airway inflammation, albeit poor, was unchanged between difficult patients intramuscular progesterone has been adthe follicular and luteal phases. This study prompts further vocated as an alternative treatment. 4 Overall, there is a research in menstruating females using other established paucity of data on underlying mechanisms and possible markers of airway inflammation. treatment regimens for premenstrual asthma. It behoves There are now several non-invasive tools to evaluate respiratory physicians to develop a programme of research airway inflammation in asthma that may be applicable in in this poorly understood subgroup of asthmatic patients. premenstrual asthma. Nitric oxide (NO), a gas present in exhaled air, is increased in patients with asthma. 9 Exhaled
